|
|
|
|
Events
|
|
|
| Back |
The biotech company Ipsogen lists on Alternext in Paris on 10 June 2008
(10/06/08)
|
 |
Ipsogen specializes in the development and marketing of molecular oncology diagnostics. Net sales break down by activity as follows:
- sale of diagnostic products (81.1%): diagnostic tests for leukemia and breast cancer sold to healthcare centers (55% of sales), retailers (39%), and private laboratories (6%). Net sales break down by country between France (22.1%), Europe (35.4%), North America (25.2%) and other (17.3%);
- services (18.9%): primarily research and development services provided to pharmaceutical and biotechnology companies.
|
| Related URL: www.ipsogen.com |
Stanislas Piot (Chief Financial Officer, Ipsogen), Yasmina Galle (Listing Department NYSE Euronext), Vincent Fert (Chief Executive Officer, Ipsogen), Annie Dupeyron (Listing Department NYSE Euronext), Catherine Trividic (Bryan Garnier) et Christian Finan (Bryan Garnier)
|
|
|
| Provider : NYSE Euronext |
|
|
|
|
|
|
|
|
|
